Newsfiscal.ai
Orchestra BioMed Announces Virtue SAB Presentation at TCT 2026
· Published
Article summary
Orchestra BioMed Holdings, Inc. announced that it will present data regarding its Virtue SAB (Sirolimus AngioInfusion Balloon) system at the Transcatheter Cardiovascular Therapeutics (TCT) 2026 conference.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…